基因仪器循环代谢物和肝胆癌症风险:一个多层次的门德尔随机化和功能质询
Lin Tuo1, Li Ting Yan1, Ying Liu1
1Department of Infectious Disease, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Frontiers in oncology
|November 12, 2025
概括
三种血清代谢物,包括4-基希普酸和3-基异酸,显示与肝胆癌风险的因果关系. 这些发现为肝癌治疗中的精准医学提供了潜在的生物标志物和治疗点.
科学领域:
- 代谢学 代谢学 代谢学
- 在瘤学瘤学.
- 遗传流行病学遗传流行病学
背景情况:
- 肝胆恶性瘤,如肝细胞癌和胆管癌,是全球癌症死亡率的重要原因.
- 这些癌症背后的精确调节途径尚未完全理解.
研究的目的:
- 调查大量血清代谢物与患肝胆癌的风险之间的潜在因果关系.
- 为了确定新的代谢生物标志物和肝胆恶性瘤的治疗点.
主要方法:
- 采用双样本的门德尔随机化 (MR) 方法,分析了1400个血清代谢物.
- 进行了严格的质量控制和灵敏度分析,包括MR-Egger回归和MR-PRESSO.
- 根据严格的统计标准确定了候选代谢物.
主要成果:
- 三种代谢物与肝胆癌风险有着强有力的关联:增加风险的二甲基氨基 (SDMA+ADMA) 和4-基氨酸,以及保护性的3-基基酸盐.
- 多变量MR证实了4-基酸盐和3-基酸盐的独立作用.
- 实验室研究表明,4-基酸盐促进肝细胞癌细胞增殖,而3-基酸盐则抑制了它.
结论:
- 这项研究增强了对肝胆癌中代谢失调的理解.
- 已识别的代谢物,特别是4-基酸盐和3-基酸盐,被提名为潜在的诊断生物标志物和治疗点.
- 这些发现为开发用于肝癌的精准医学策略提供了基础.
相关概念视频
Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
171
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
171


